Not checked for notices yet.
Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms
Ellen C. Moore, Lillian Sun, Paul E. Clavijo and 6 more
OncoImmunology · 2018
doi:10.1080/2162402x.2017.1404216
Cited by papers we hold 2
- Gene Therapy in Cancer Treatment: Why Go Nano? · 2020No notice
- Detection of immunogenic cell death and its relevance for cancer therapy · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.